American Health Policy Institute’s CEO Tevi Troy recently commented on President Donald Trump’s nomination of Alex Azar as Health and Human Services (HHS) secretary.

EMD Serono, Merck KGaA’s U.S. and Canada-based biopharmaceutical business, recently received Food and Drug Administration approval for a redesigned version of a pen injector, designed to be used to induce ovulation and pregnancy in certain oligo-anovulatory women.

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has issued a positive opinion of AstraZeneca's and MedImmune's benralizumab, which is designed to treat adults with severe eosinophilic asthma.

AstraZeneca and MedImmune, its department for global biologics research and development, recently gave 28 presentations at the American Heart Association (AHA) Scientific Sessions, which took place Nov. 11-15 in Anaheim, California.

Wake Forest Baptist Medical Center detailed the story of a local two-year old kidney transplant recipient in a recent press release.

Over the past year, Wake Forest Baptist Medical Center helped a new father overcome a lifelong struggle and lose more than 100 pounds, according to a press release.

A study of Novartis' Cosentyx shows promising results in reducing the signs and symptoms of psoriatic arthritis (PsA).

New surveys using data from ArthritisPower and CreakyJoints, part of the Global Healthy Living Foundation show women living with rheumatoid arthritis (RA) lack the information and resources to make confident decisions when it comes to reproductive health and family planning.

A study published in Nutrition & Diabetes shows that fruits blended in a NutriBullet provide the same glucose response as fruits consumed whole, which could be beneficial for people who need to monitor their glucose levels.

The Partnership to Fight Chronic Disease (PFCD) recently hosted a health observance briefing for National Diabetes Heart Connection Day to raise awareness of the link between diabetes and cardiovascular disease.

Novartis' long-term data for Cosentyx, a treatment for patients with ankylosing spondylitis (AS), show positive outcomes, including improvement of symptoms in 80 percent of patients.

The American Medical Association (AMA) recently released a report that details how market concentration and consolidation is causing a trend of higher premiums for consumers and lower payments for physician services.

The National Institutes of Health recently said it will fund a total of $169 million for 110 new awards for the Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative.

Though migraines are often misunderstood and frequently undiagnosed, effective treatment for migraine sufferers exists, according to the Wake Forest Baptist Medical Center.

Events for those living with primary biliary cholangitis (PBC) have been scheduled at locations across the United States, the American Autoimmune and Related Diseases Association announced.

Stony Brook University Medical Center will bring together leaders in the neuroscience field from around the nation at its second annual “Meeting of the Minds” symposium on Nov. 4 at the East Campus.

AbbVie plans to present data from 38 abstracts of Humira (adalimumab) and other products in the company’s investigational immunology medicine portfolio at the 2017 American College of Rheumatology (ACR)/Association for Rheumatology Health Professionals (ARHP) annual meeting Nov. 3-8, in San Diego.

Amgen recently launched At Home with Joan, a cancer information awareness campaign spearheaded by Joan Lunden, a breast cancer survivor and former co-host of "Good Morning America."

Abbott said its Confirm Rx Insertable Cardiac Monitor (ICM), a smartphone compatible ICM to help physicians identify cardiac arrhythmias remotely, has been cleared by the U.S. Food and Drug Administration (FDA).

Massachusetts General Hospital (MGH) researchers recently found differences in gene transcription in immune cells that could help doctors determine which patients with the hepatitis C virus (HCV) develop chronic infection those whose immune systems can clear the virus.